Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Maier-Lenz

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 23, 2003
[Clinical trials in Germany: steadily progressing!]H Maier-Lenz
Arzneimittel-Forschung|January 1, 1982
[Comparative pharmacokinetics and relative bioavailability of the active principles diazepam, acetylsalicylic acid, caffeine, and dihydroergotamine tartrate in a combination product]J Degen, H Maier-Lenz
Arzneimittel-Forschung|January 1, 1984
[Comparative pharmacokinetics and biologic availability of paracetamol as suppositories]J Degen, H Maier-Lenz
Arzneimittel-Forschung|January 1, 1981
[A comparative pharmacokinetic study for tablet and suppository formulations of a combination product of caffeine, ethaverine, propyphenazone, paracetamol and phenobarbital (author's transl)]H Maier-Lenz, L Ringwelski, A Windorfer
Arzneimittel-Forschung|May 1, 1988
[The effect of time and dosage of isosorbide mononitrate on objective and subjective parameters in angina pectoris]H Herrmann, A Kuhl, H Maier-Lenz
Arzneimittel-Forschung|July 1, 1989
Tolerance and pharmacokinetics of a new antiulcer compound in man after single oral dosesB Uckert, S Kobayashi, H Maier-Lenz
Arzneimittel-Forschung|January 1, 1979
Comparative pharmacokinetics and relative bioavailability for different preparations of nitrofurantoinH Maier-Lenz, L Ringwelski, A Windorfer
Arzneimittel-Forschung|January 1, 1982
[On the pharmacokinetics and bioavailability of paracetamol in suppositories for paediatry (author's transl)]H Degen, H Maier-Lenz, A Windorfer
Arzneimittel-Forschung|January 1, 1980
[Pharmacokinetics and bioavailability of the myotonolytic N-(hydroxy-2-ethyl)-cinnamide (author's transl)]H Maier-Lenz, L Ringwelski, A Windorfer
Arzneimittel-Forschung|January 1, 1982
[Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations]A Geigenberger, J Degen, H Maier-Lenz
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Deutsche Medizinische Wochenschrift (1946)|September 23, 2003
[Clinical trials in Germany: steadily progressing!]H Maier-Lenz
Arzneimittel-Forschung|January 1, 1982
[Comparative pharmacokinetics and relative bioavailability of the active principles diazepam, acetylsalicylic acid, caffeine, and dihydroergotamine tartrate in a combination product]J Degen, H Maier-Lenz
Arzneimittel-Forschung|January 1, 1984
[Comparative pharmacokinetics and biologic availability of paracetamol as suppositories]J Degen, H Maier-Lenz
Arzneimittel-Forschung|January 1, 1981
[A comparative pharmacokinetic study for tablet and suppository formulations of a combination product of caffeine, ethaverine, propyphenazone, paracetamol and phenobarbital (author's transl)]H Maier-Lenz, L Ringwelski, A Windorfer
Arzneimittel-Forschung|May 1, 1988
[The effect of time and dosage of isosorbide mononitrate on objective and subjective parameters in angina pectoris]H Herrmann, A Kuhl, H Maier-Lenz
Arzneimittel-Forschung|July 1, 1989
Tolerance and pharmacokinetics of a new antiulcer compound in man after single oral dosesB Uckert, S Kobayashi, H Maier-Lenz
Arzneimittel-Forschung|January 1, 1979
Comparative pharmacokinetics and relative bioavailability for different preparations of nitrofurantoinH Maier-Lenz, L Ringwelski, A Windorfer
Arzneimittel-Forschung|January 1, 1982
[On the pharmacokinetics and bioavailability of paracetamol in suppositories for paediatry (author's transl)]H Degen, H Maier-Lenz, A Windorfer
Arzneimittel-Forschung|January 1, 1980
[Pharmacokinetics and bioavailability of the myotonolytic N-(hydroxy-2-ethyl)-cinnamide (author's transl)]H Maier-Lenz, L Ringwelski, A Windorfer
Arzneimittel-Forschung|January 1, 1982
[Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations]A Geigenberger, J Degen, H Maier-Lenz
Pageof 3